Soluble TNF Receptors and Albuminuria in Non-obese Japanese Type 2 Diabetic Patients

Abstract

The aim of this study was to investigate the relationships between albuminuria and tumor necrosis factor (TNF)-α or soluble TNF receptors (sTNF-R1, sTNF-R2) in eighty-eight non-obese Japanese type 2 diabetic patients stratified into two groups according to albuminuria status-microalbuminuria or normoalbuminuria. Patients with microalbuminuria were older and had significantly higher concentrations of sTNF-R1 and sTNF-R2 than those with normoalbuminuria. There was, however, no significant difference in sex, diabetes duration, smoking, BMI, systolic and diastolic blood pressure, HbA_1c, serum creatinine, and lipid profile between the two groups. Although serum TNF-α was positively correlated to serum sTNF-R1 and sTNF-R2, serum TNF-α level did not differ with respect to albuminuria. Univariate regression analysis showed that urinary albumin concentration was positively correlated to age (r = 0.380, p < 0.001), serum creatinine (r = 0.214, p < 0.05) and concentrations of sTNF-R1 (r = 0.364, p < 0.001) and sTNF-R2 (r = 0.342, p < 0.005). Other variables, including TNF-α, were not associated with albuminuria. Multiple regression analyses showed that urinary albumin concentration was independently predicted by the level of sTNF-R1 (F = 32.1), which explained 26.3 % of the variability of urinary albumin concentration. From these results, it can be concluded that serum soluble TNF receptor is an important independent factor associated with albuminuria in non-obese Japanese type 2 diabetic patients.

sTNF receptors - TNF-alpha - Albuminuria - Diabetes

• 1 Fuller H, Shipley M J, Rose G, Jarrett R J, Keen H. Coronary heart disease risk and impaired glucose tolerance.  Lancet. 1980;  1 1373-1376
• 2 Yano K, Kagan A, McGee D, Rhoads G G. Glucose intolerance and nine-year mortality in Japanese men in Hawaii.  Am J Med. 1982;  72 71-80
• 3 Diabetes Drafting Group . Prevalence of small vessel and large vessel disease in diabetic persons from 14 centers: the World Health Organization multinational study of vascular disease in diabetics.  Diabetologia. 1985;  28 615-640
• 4 Herman J B, Medalie J H, Goldbourt U. Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabetics.  Diabetologia. 1977;  13 229-234
• 5 Mogensen C E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.  N Engl J Med. 1984;  310 356-360
• 6 Festa A, D’Agostino R, Howard G, Mykkanen L, Tracy R P, Haffner S M. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The insulin resistance atherosclerosis study.  Kidney Int. 2000;  58 1703-1710
• 7 Stehouwer C DA, Gall M A, Twisk J WR, Knudsen E, Emeis J J, Parving H H. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Progressive, interrelated, and independently associated with risk of death.  Diabetes. 2002;  51 1157-1165
• 8 Smith C A, Farrah T, Goodwin R G. TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death.  Cell. 1994;  76 959-962
• 9 Tartaglia L A, Weber R F, Figari I S, Reynolds S, Pailadino M A Jr, Goeddel D V. The two different receptors.  Proc Natl Acad Sci USA. 1991;  88 9292-9296
• 10 Tartaglia L A, Goeddel D V. Two TNF receptors.  Immunol Today. 1992;  13 151-153
• 11 Rauchhaus M, Doehner W, Francis D P, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk H D, Coats A JS, Anker S D. Plasma cytokine parameters and mortality in patients with chronic heart failure.  Circulation. 2000;  102 3060-3067
• 12 Zoppini G, Faccini G, Muggeo M, Zenari L, Falezza G, Targher G. Elevated plasma levels of soluble receptors of TNF-α and their association with smoking and microvascular complications in young adults with type 1 diabetes.  J Clin Endocrinol Metab. 2001;  186 3805-3808
• 13 Hotamisligil G S, Shargil N S, Spiegelman B M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.  Science. 1993;  259 87-91
• 14 Tanaka S, Seino H, Satoh J, Fujii N, Rikiishi H, Zhu X P, Takahashi K, Sagara M, Nobunaga T, Toyota T. Increased in vivo production of tumor necrosis factor after development of diabetes in non-treated, long-term diabetic BB rats.  Clin Immunol Immunopathol. 1992;  62 258-263
• 15 Taniguchi A, Nakai Y, Doi K, Fukuzawa H, Fukushima M, Kawamura H, Tokuyama K, Suzuki M, Fujitani J, Tanaka H, Nagata I. Insulin sensitivity, insulin secretion, and glucose effectiveness in obese subjects: a minimal model analysis.  Metabolism. 1995;  44 1397-1400
• 16 World Health Organization .Diabetes Mellitus: Report of a WHO Study Group. Geneva; World Health Org 1985 (Tech. Rep. Ser., no 727)
• 17 Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.  Clin Chem. 1972;  18 499-502
• 18 Nakai Y, Hamagaki S, Seino Y, Takagi R, Taniguchi A, Kurimoto F. Plasma concentrations of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in patients with anorexia nervosa.  J Clin Endocrinol Metab. 1999;  84 1226-1228
• 19 Gatling W, Knight C, Hill R D. Screening for early diabetic nephropathy: which sample to detect microalbuminuria?.  Diabetic Med. 1985;  2 451-455
• 20 Cowell C T, Rodgers S, Silkink M. First morning urinary albumin concentration is a good predictor of 24-hour urinary albumin excretion in children with type 1 (insulin-dependent) diabetes.  Diabetologia. 1986;  29 97-99
• 21 Hutchison A S, O’Reilly D SJ, McCuish A C. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria.  Clin Chem. 1988;  34 2019-2021
• 22 American Diabetes Associations . Nephropathy in diabetes.  Diabetes Care. 2004;  27 579-583
• 23 Groop L, Ekstrand A, Forsblom C, Widen E, Groop P H, Teppo A M, Eriksson J. Insulin resistance, hypertension, and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.  Diabetologia. 1993;  36 642-647
• 24 Gabazza E C, Takeya H, Debuchi H, Sumida Y, Taguchi O, Murata K, Nakatani K, Yano Y, Mohri M, Sata M, Shima T, Nishioka J, Suzuki K. Protein C activation in NIDDM patients.  Diabetologia. 1996;  39 1455-1461
• 25 Nielsen S, Schmitz A, Bacher T, Rehling M, Ingerslev J, Mogensen C E. Transcapillary escape rate and albuminuria in type II diabetes: Effects of short-term treatment with low-molecular weight heparin.  Diabetologia. 1999;  42 60-67
• 26 Chen J W, Gall M A, Yokoyama H, Jensen J S, Deckert M, Parving H H. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.  Diabetes Care. 1996;  19 130-134
• 27 Baud L, Ardaillou R. Tumor necrosis factor alpha in glomerular injury.  Kidney Int. 1994;  45 (Suppl 45) S32-S36
• 28 Klein N J, Shennan G I, Heyderman R S, Levin M. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin, and neutrophils.  J Cell Sci. 1992;  102 821-832
• 29 Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, Koide H. mRNA expression of growth factors in glomeruli from diabetic rats.  Diabetes. 1993;  42 450-456
• 30 Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern D M, Schmidt A M, De Caterina R. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE. A mechanism for amplification of inflammatory responses.  Circulation. 2002;  105 816-822
• 31 Ruits-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J. Proinflammatory actions of angiotensins.  Curr Opin Nephrol Hypertens. 2001;  10 321-329
• 32 Hotamisligil G S, Arner P, Atkinson R L, Spiegelman M. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance.  Diabetes. 1997;  46 451-455
• 33 Fernandez-Real J M, Broch M, Ricart W, Casmitjana R, Gutierrez C, Vendrell J, Richart C. Plasma levels of the soluble fraction of tumor necrosis factor 2 and insulin resistance.  Diabetes. 1998;  47 1757-1762
• 34 Liu L S, Spelleken M, Rohrig K, Hauner H, Eckel J. Tumor necrosis factor-α acutely inhibits insulin signaling in human adipocytes. Implication of the p80 tumor necrosis factor receptor.  Diabetes. 1998;  47 515-522
• 35 Vandenabeele P, Declercq W, Beyaert R, Fiers W. Two tumor necrosis factor receptors: structure and function.  Trends in Cell Bilogy. 1995;  5 392-399
• 36 Pichler R, Maschek W, Hatzl-Griesenhofer M, Huber H, Crespillo-Gomez C, Berg J. Soluble tumor necrosis factor-α receptor 1 and interleukin-6 as markers of activity in thyrotoxic Graves’ disease.  Horm Metab Res. 2003;  35 427-433